The End of Alzheimer's Programme (ePub)

Name: The End of Alzheimer's Programme
Brand: Ebury Publishing
SKU: 112888311
Price: 14.99 EUR
Availability: OnlineOnly

The Practical Plan to Prevent and Reverse Cognitive Decline at Any Age (Sprache: Englisch)

Autor: Dale Bredesen

Schreiben Sie einen Kommentar zu "The End of Alzheimer's Programme".

The End of Alzheimer's Programme, Dale Bredesen

Merken

The scientifically-proven practical plan to help reverse Alzheimer's and prevent cognitive decline from the international bestselling author of The End of Alzheimer's.

Following his ground-breaking book that transformed how we think about...

Mehr zum Inhalt Family Sharing Autorenporträt Video

eBook (ePub) 14.99 €

Buch (Kartoniert) 22.10 €

sofort als Download lieferbar

Bestellnummer: 112888311

Printausgabe 22.10 €

eBook (ePub) -32% 14.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails
Download-DRM Infos
Family Sharing

Produktinformationen zu „The End of Alzheimer's Programme (ePub)“

The scientifically-proven practical plan to help reverse Alzheimer's and prevent cognitive decline from the international bestselling author of The End of Alzheimer's.

Following his ground-breaking book that transformed how we think about Alzheimer's and its treatment, world-renowned neurology expert Dale Bredesen provides an unprecedented hands-on guide to achieving complete brain health.

In The End of Alzheimer's Programme, he lays out step-by-step his highly sought after, scientifically-proven method that you can follow with a healthcare professional to stop Alzheimer's in its tracks.

Alzheimer's Disease is a protective response to an array of factors that directly affect the brain, such as inflammation, genetic inheritance, nutrients and hormones. In this book, Bredesen will show you which of these factors you need to address to enhance your cognitive abilities by laying out a personalised lifestyle plan. Covering sleep, exercise, diet, brain training and more, Bredesen will show you how to retain, regain and maximise cognitive function for any ability and for any age with extraordinary results.

Based on cutting-edge research and full of inspiring success stories from Bredesen's patients, this book is a must-read for anyone looking to enhance their brainpower and is a vital guide for carers and healthcare professionals.

Autoren-Porträt von Dale Bredesen

Dale Bredesen, MD, is internationally recognised as an expert in the mechanisms of neurodegenerative diseases, such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as its founding president and CEO. He is Professor of Neurology at the University of California, Los Angeles.

eBook Hilfe

Informationen und Hilfe zu eBooks hier klicken!

Bibliographische Angaben

Autor: Dale Bredesen
2020, Englisch
Verlag: Ebury Publishing
ISBN-10: 1473564166
ISBN-13: 9781473564169
Erscheinungsdatum: 20.08.2020

Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.

eBook Informationen

Dateiformat: ePub
Größe: 14 MB
Mit Kopierschutz
Vorlesefunktion

Sprache:

Englisch

Kopierschutz

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.

Family Sharing

eBooks und Audiobooks (Hörbuch-Downloads) mit der Familie teilen und gemeinsam genießen. Mehr Infos hier.

Kommentar zu "The End of Alzheimer's Programme"

Schreiben Sie einen Kommentar zu "The End of Alzheimer's Programme".